Mutual Fund Ownership
Ownership as on: Sun, 23 Jun, 2024

DSP Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)131.41
% of AUM5.56%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)22.19
% of AUM3.25%

Kotak Small Cap Growth

3/5
Equity
Amount Invested (Cr.)317.68
% of AUM2.08%

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.03
% of AUM1.93%

DSP Midcap Fund Growth

2/5
Equity
Amount Invested (Cr.)296.37
% of AUM1.68%

FAQs about Alembic Pharmaceuticals share price

Alembic Pharmaceuticals is trading at 870.35 as on Fri Jun 21 2024 09:59:03. This is 2.98% upper as compared to its previous closing price of 845.20.

The market capitalization of Alembic Pharmaceuticals is 17107.87 Cr as on Fri Jun 21 2024 09:59:03.

The average broker rating on Alembic Pharmaceuticals is Hold. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 0 analysts have given a buy rating
  • 6 analysts have given a hold rating
  • 2 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Alembic Pharmaceuticals is 1093.05 whereas the 52 wk low is 600.65

Alembic Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 31.42
  • Sector P/E: 34.35
  • Dividend Yield: 1.30%
  • D/E ratio: 0.11

Alembic Pharmaceuticals reported a net profit of 615.82 Cr in 2024.

Recommended For You
Trending Stocks
1,413.25+32.10(2.32%)
1,531.70+16.40(1.08%)
10,662.95-242.55 (-2.22%)
3,533.10-64.00 (-1.78%)
HomeMarketsPremiumInstant LoanGet App